Medical therapy of Crohn's disease

Shamina Dhillon, Edward Vincent Loftus, Jr

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

There is no medical or surgical treatment that provides a permanent cure for Crohn's disease (CD). However, an evolving understanding of the pathogenesis of CD has provided clinicians with a diversity of medical treatment options for the disease. The goal of therapy is to induce and maintain clinical remission. The efficacy of immune-modifying agents such as azathioprine/6-mercaptopurine and infliximab have supported a paradigm shift in CD treatment in which maintenance agents are introduced earlier in the disease course. At the same time, it is imperative to balance the efficacy, safety, and tolerability of medical therapy. Given the variable and relapsing clinical course of CD, the physician and patient should ideally develop an ongoing relationship that allows for individualization of treatment regimens, monitoring of response and side effects, and modification of the therapeutic strategy in the absence of improvement.

Original languageEnglish (US)
Pages (from-to)19-30
Number of pages12
JournalCurrent Treatment Options in Gastroenterology
Volume8
Issue number1
StatePublished - Feb 2005

Fingerprint

Crohn Disease
Therapeutics
6-Mercaptopurine
Azathioprine
Therapeutic Uses
Maintenance
Physicians
Safety

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Medical therapy of Crohn's disease. / Dhillon, Shamina; Loftus, Jr, Edward Vincent.

In: Current Treatment Options in Gastroenterology, Vol. 8, No. 1, 02.2005, p. 19-30.

Research output: Contribution to journalReview article

@article{15d55c76e7aa4b7b9bcf6ff91d554a4d,
title = "Medical therapy of Crohn's disease",
abstract = "There is no medical or surgical treatment that provides a permanent cure for Crohn's disease (CD). However, an evolving understanding of the pathogenesis of CD has provided clinicians with a diversity of medical treatment options for the disease. The goal of therapy is to induce and maintain clinical remission. The efficacy of immune-modifying agents such as azathioprine/6-mercaptopurine and infliximab have supported a paradigm shift in CD treatment in which maintenance agents are introduced earlier in the disease course. At the same time, it is imperative to balance the efficacy, safety, and tolerability of medical therapy. Given the variable and relapsing clinical course of CD, the physician and patient should ideally develop an ongoing relationship that allows for individualization of treatment regimens, monitoring of response and side effects, and modification of the therapeutic strategy in the absence of improvement.",
author = "Shamina Dhillon and {Loftus, Jr}, {Edward Vincent}",
year = "2005",
month = "2",
language = "English (US)",
volume = "8",
pages = "19--30",
journal = "Current Treatment Options in Gastroenterology",
issn = "1092-8472",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - Medical therapy of Crohn's disease

AU - Dhillon, Shamina

AU - Loftus, Jr, Edward Vincent

PY - 2005/2

Y1 - 2005/2

N2 - There is no medical or surgical treatment that provides a permanent cure for Crohn's disease (CD). However, an evolving understanding of the pathogenesis of CD has provided clinicians with a diversity of medical treatment options for the disease. The goal of therapy is to induce and maintain clinical remission. The efficacy of immune-modifying agents such as azathioprine/6-mercaptopurine and infliximab have supported a paradigm shift in CD treatment in which maintenance agents are introduced earlier in the disease course. At the same time, it is imperative to balance the efficacy, safety, and tolerability of medical therapy. Given the variable and relapsing clinical course of CD, the physician and patient should ideally develop an ongoing relationship that allows for individualization of treatment regimens, monitoring of response and side effects, and modification of the therapeutic strategy in the absence of improvement.

AB - There is no medical or surgical treatment that provides a permanent cure for Crohn's disease (CD). However, an evolving understanding of the pathogenesis of CD has provided clinicians with a diversity of medical treatment options for the disease. The goal of therapy is to induce and maintain clinical remission. The efficacy of immune-modifying agents such as azathioprine/6-mercaptopurine and infliximab have supported a paradigm shift in CD treatment in which maintenance agents are introduced earlier in the disease course. At the same time, it is imperative to balance the efficacy, safety, and tolerability of medical therapy. Given the variable and relapsing clinical course of CD, the physician and patient should ideally develop an ongoing relationship that allows for individualization of treatment regimens, monitoring of response and side effects, and modification of the therapeutic strategy in the absence of improvement.

UR - http://www.scopus.com/inward/record.url?scp=13944265062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944265062&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:13944265062

VL - 8

SP - 19

EP - 30

JO - Current Treatment Options in Gastroenterology

JF - Current Treatment Options in Gastroenterology

SN - 1092-8472

IS - 1

ER -